Investing & Markets

Dogwood Therapeutics Soars 37% on Cancer Pain Drug License Deal

Dogwood Therapeutics Soars 37% on Cancer Pain Drug License Deal

Dogwood Therapeutics Soars: A Deep Dive into Its Cancer Pain Treatment License Deal The biotechnology sector, known for its volatile yet potentially rewarding nature, is once again demonstrating its capacity for dramatic shifts. As of early trading on September 29, 2025, Dogwood Therapeutics (DWTX) shares experienced an extraordinary surge, climbing an impressive 37% to approximately $7.58. This significant market movement is directly attributable to a groundbreaking announcement: Dogwood Therapeutics has successfully secured a worldwide, royalty-free license for a promising new treatment targeting the severe and often debilitating pain associated with cancer therapy. This strategic acquisition is generating considerable excitement among investors and medical professionals alike, signaling a potentially transformative development in oncology pain management. Unpacking the Catalyst: A New Approach to Cancer Pain Cancer treatments, while life-saving, frequently inflict a severe side effect…

Post a Comment

<script type="text/javascript" src="https://www.blogger.com/static/v1/widgets/2536035415-widgets.js"></script>
<script type='text/javascript'>
window['__wavt'] = 'AOuZoY56IfPAu-OJgXZGg3nidtRqRf_SkQ:1759181270925';_WidgetManager._Init('//www.blogger.com/rearrange?blogID\x3d7670458792165888524','//www.finqura.com/2025/09/dogwood-therapeutics-soars-37-on-cancer.html?amp\x3d1','7670458792165888524');
_WidgetManager._SetDataContext([{'name': 'blog', 'data': {'blogId': '7670458792165888524', 'title': 'FinQura.com', 'url': 'https://www.finqura.com/2025/09/dogwood-therapeutics-soars-37-on-cancer.html?amp\x3d1', 'canonicalUrl': 'https://www.finqura.com/2025/09/dogwood-therapeutics-soars-37-on-cancer.html', 'homepageUrl': 'https://www.finqura.com/?amp\x3d1', 'searchUrl': 'https://www.finqura.com/search', 'canonicalHomepageUrl': 'https://www.finqura.com/', 'blogspotFaviconUrl': 'https://www.finqura.com/favicon.ico', 'bloggerUrl': 'https://www.blogger.com', 'hasCustomDomain': true, 'httpsEnabled': true, 'enabledCommentProfileImages': true, 'gPlusViewType': 'FILTERED_POSTMOD', 'adultContent': false, 'analyticsAccountNumber': 'G-VVYFGEFT7V', 'analytics4': true, 'encoding': 'UTF-8', 'locale': 'en', 'localeUnderscoreDelimited': 'en', 'languageDirection': 'ltr', 'isPrivate': false, 'isMobile': false, 'isMobileRequest': false, 'mobileClass': '', 'isPrivateBlog': false, 'isDynamicViewsAvailable': true, 'feedLinks': '\x3clink rel\x3d\x22alternate\x22 type\x3d\x22application/atom+xml\x22 title\x3d\x22FinQura.com - Atom\x22 href\x3d\x22https://www.finqura.com/feeds/posts/default\x22 /\x3e\n\x3clink rel\x3d\x22alternate\x22 type\x3d\x22application/rss+xml\x22 title\x3d\x22FinQura.com - RSS\x22 href\x3d\x22https://www.finqura.com/feeds/posts/default?alt\x3drss\x22 /\x3e\n\x3clink rel\x3d\x22service.post\x22 type\x3d\x22application/atom+xml\x22 title\x3d\x22FinQura.com - Atom\x22 href\x3d\x22https://www.blogger.com/feeds/7670458792165888524/posts/default\x22 /\x3e\n\n\x3clink rel\x3d\x22alternate\x22 type\x3d\x22application/atom+xml\x22 title\x3d\x22FinQura.com - Atom\x22 href\x3d\x22https://www.finqura.com/feeds/3642570370595824773/comments/default\x22 /\x3e\n', 'meTag': '', 'adsenseHostId': 'ca-host-pub-1556223355139109', 'adsenseHasAds': false, 'adsenseAutoAds': false, 'boqCommentIframeForm': true, 'loginRedirectParam': '', 'view': '', 'dynamicViewsCommentsSrc': '//www.blogblog.com/dynamicviews/4224c15c4e7c9321/js/comments.js', 'dynamicViewsScriptSrc': '//www.blogblog.com/dynamicviews/8f4b520d26f96f21', 'plusOneApiSrc': 'https://apis.google.com/js/platform.js', 'disableGComments': true, 'interstitialAccepted': false, 'sharing': {'platforms': [{'name': 'Get link', 'key': 'link', 'shareMessage': 'Get link', 'target': ''}, {'name': 'Facebook', 'key': 'facebook', 'shareMessage': 'Share to Facebook', 'target': 'facebook'}, {'name': 'BlogThis!', 'key': 'blogThis', 'shareMessage': 'BlogThis!', 'target': 'blog'}, {'name': 'X', 'key': 'twitter', 'shareMessage': 'Share to X', 'target': 'twitter'}, {'name': 'Pinterest', 'key': 'pinterest', 'shareMessage': 'Share to Pinterest', 'target': 'pinterest'}, {'name': 'Email', 'key': 'email', 'shareMessage': 'Email', 'target': 'email'}], 'disableGooglePlus': true, 'googlePlusShareButtonWidth': 0, 'googlePlusBootstrap': '\x3cscript type\x3d\x22text/javascript\x22\x3ewindow.___gcfg \x3d {\x27lang\x27: \x27en\x27};\x3c/script\x3e'}, 'hasCustomJumpLinkMessage': false, 'jumpLinkMessage': 'Read more', 'pageType': 'item', 'postId': '3642570370595824773', 'postImageUrl': 'https://image.pollinations.ai/prompt/A%20dynamic%20and%20futuristic%20image%20depicting%20a%20biotech%20laboratory%20scene%20with%20researchers%20working%20on%20advanced%20equipment.%20In%20the%20foreground%2C%20a%20glowing%20molecular%20structure%20or%20a%20conceptual%20representation%20of%20a%20drug%20interacts%20with%20nerve%20endings%2C%20symbolizing%20pain%20relief%20and%20nerve%20repair.%20In%20the%20background%2C%20subtly%20integrated%2C%20there\x27s%20a%20stock%20chart%20showing%20an%20upward%20trend%20and%20a%20silhouette%20of%20a%20dogwood%20flower.%20The%20overall%20tone%20is%20hopeful%20and%20innovative%2C%20blending%20science%20with%20financial%20growth.', 'pageName': 'Dogwood Therapeutics Soars 37% on Cancer Pain Drug License Deal', 'pageTitle': 'FinQura.com: Dogwood Therapeutics Soars 37% on Cancer Pain Drug License Deal', 'metaDescription': ''}}, {'name': 'features', 'data': {}}, {'name': 'messages', 'data': {'edit': 'Edit', 'linkCopiedToClipboard': 'Link copied to clipboard!', 'ok': 'Ok', 'postLink': 'Post Link'}}, {'name': 'template', 'data': {'name': 'custom', 'localizedName': 'Custom', 'isResponsive': true, 'isAlternateRendering': false, 'isCustom': true}}, {'name': 'view', 'data': {'classic': {'name': 'classic', 'url': '?view\x3dclassic'}, 'flipcard': {'name': 'flipcard', 'url': '?view\x3dflipcard'}, 'magazine': {'name': 'magazine', 'url': '?view\x3dmagazine'}, 'mosaic': {'name': 'mosaic', 'url': '?view\x3dmosaic'}, 'sidebar': {'name': 'sidebar', 'url': '?view\x3dsidebar'}, 'snapshot': {'name': 'snapshot', 'url': '?view\x3dsnapshot'}, 'timeslide': {'name': 'timeslide', 'url': '?view\x3dtimeslide'}, 'isMobile': false, 'title': 'Dogwood Therapeutics Soars 37% on Cancer Pain Drug License Deal', 'description': 'FinQura: Real-time fintech news on AI, crypto \x26 startups. Deep analysis for investors \x26 innovators. Financial Quality Research Aura. Stay ahead.', 'featuredImage': 'https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tn0FMs7tqdP1jMRqFgZ3gVF2iePoDdiz146IlEuR-93ppifEAsSGX6-XXjSIsyuAjps_cS3lQjt6BMXJPeWYVacgO6250rjY9wmR2DWgey4I5tr6C_k6p8_mhJNsO8lO58odfV6S9r4-XjlyxbLiFVQDgV_PnJ7-jGDLyfO5VKn3X-37ePly02x1vDM2ZVjHmwsWMHe4bzL0Mel88AiBxAQEzsDWGb00k42DP8bcdi7JOLNszzkf40W4OesqnWlkcabhYY2TXlZaPh5EG5atXMq0f-Qb0LIE20dx3ZwjAnIeLvqCQgIm7uWMVpLMa22t_R6R20bdNt9Bfo_PeekOB2U1ugZzRcYl1pXjwx4J6qlPY2mPtTVxqN7iyUlJ9ha89dvEy_5gyBNUyi0g8giN-bFrWfdZTACaKktnDipE2kV3mXAW4wyo_eFunqHinasV9Te9hlCobUj9u2yMQQ_6Gk5U1oXhe9EU17NyYoX0SmL8TleHAnwqNvbI42i8uZ1eXpVPXgeqHnCI3fLF2jziGu1oTanClr8kQZdHmGjGDlbfgwRLYd0XT0iQIrwwnZAo-tZY12-rAXkPbn71wJsZkJxNh6H0heh5WegcTewrJrX4Ig0jWOxIYgPOp7gN4TAZhASPcyrwA3OYTWKuOVisXA2l_M9T-7iTqRs2Kt7aGU8SigHtZm86aQ0YffoPw8lLVsIphBmfJTrSSF_2UJFKCNQqvAErSgHx-z2ytdGfINBP46B71RY7aiuqSmADCe7NmW_FmW8ATMBgvqyKIk_j5IE5JXo7LnyHzerDp_caRxul7nDErnV6p6rOjbENzFN8M0WZLUBnztLSdyBv70LAGmJi2SEgvfYyDxklBbENKL9diT3OvJ-OqEXY2G5XEevYvXabSPNjg29V9OCwqAuRJBYz-oBXRFx4SEMn6HcLhuqGkVIgQ', 'url': 'https://www.finqura.com/2025/09/dogwood-therapeutics-soars-37-on-cancer.html?amp\x3d1', 'type': 'item', 'isSingleItem': true, 'isMultipleItems': false, 'isError': false, 'isPage': false, 'isPost': true, 'isHomepage': false, 'isArchive': false, 'isLabelSearch': false, 'postId': 3642570370595824773}}, {'name': 'widgets', 'data': [{'title': 'FinQura.com (Header)', 'type': 'Header', 'sectionId': 'sec_Header_Title', 'id': 'Header01'}, {'title': 'Looking for something?', 'type': 'BlogSearch', 'sectionId': 'sec_Header_Search', 'id': 'BlogSearch01'}, {'title': 'Header Icon', 'type': 'TextList', 'sectionId': 'sec_Header_Icon', 'id': 'TextList01'}, {'title': 'Bookmark Posts', 'type': 'LinkList', 'sectionId': 'sec_Header_Icon', 'id': 'LinkList02'}, {'title': 'Translate', 'type': 'LinkList', 'sectionId': 'sec_Header_Icon', 'id': 'LinkList03'}, {'title': 'Navigation Menu (Simple)', 'type': 'PageList', 'sectionId': 'sec_Nav_Widgets_1', 'id': 'PageList01'}, {'title': 'Additional Links', 'type': 'PageList', 'sectionId': 'sec_Nav_Widgets_2', 'id': 'PageList02'}, {'title': 'Social Links', 'type': 'LinkList', 'sectionId': 'sec_Nav_Widgets_2', 'id': 'LinkList04'}, {'title': 'Pinned Post', 'type': 'FeaturedPost', 'sectionId': 'sec_Top_Widgets', 'id': 'FeaturedPost01', 'postId': '6033490816733727276'}, {'title': 'Blog Posts', 'type': 'Blog', 'sectionId': 'sec_Main_Widgets', 'id': 'Blog01', 'posts': [{'id': '3642570370595824773', 'title': 'Dogwood Therapeutics Soars 37% on Cancer Pain Drug License Deal', 'featuredImage': 'https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tn0FMs7tqdP1jMRqFgZ3gVF2iePoDdiz146IlEuR-93ppifEAsSGX6-XXjSIsyuAjps_cS3lQjt6BMXJPeWYVacgO6250rjY9wmR2DWgey4I5tr6C_k6p8_mhJNsO8lO58odfV6S9r4-XjlyxbLiFVQDgV_PnJ7-jGDLyfO5VKn3X-37ePly02x1vDM2ZVjHmwsWMHe4bzL0Mel88AiBxAQEzsDWGb00k42DP8bcdi7JOLNszzkf40W4OesqnWlkcabhYY2TXlZaPh5EG5atXMq0f-Qb0LIE20dx3ZwjAnIeLvqCQgIm7uWMVpLMa22t_R6R20bdNt9Bfo_PeekOB2U1ugZzRcYl1pXjwx4J6qlPY2mPtTVxqN7iyUlJ9ha89dvEy_5gyBNUyi0g8giN-bFrWfdZTACaKktnDipE2kV3mXAW4wyo_eFunqHinasV9Te9hlCobUj9u2yMQQ_6Gk5U1oXhe9EU17NyYoX0SmL8TleHAnwqNvbI42i8uZ1eXpVPXgeqHnCI3fLF2jziGu1oTanClr8kQZdHmGjGDlbfgwRLYd0XT0iQIrwwnZAo-tZY12-rAXkPbn71wJsZkJxNh6H0heh5WegcTewrJrX4Ig0jWOxIYgPOp7gN4TAZhASPcyrwA3OYTWKuOVisXA2l_M9T-7iTqRs2Kt7aGU8SigHtZm86aQ0YffoPw8lLVsIphBmfJTrSSF_2UJFKCNQqvAErSgHx-z2ytdGfINBP46B71RY7aiuqSmADCe7NmW_FmW8ATMBgvqyKIk_j5IE5JXo7LnyHzerDp_caRxul7nDErnV6p6rOjbENzFN8M0WZLUBnztLSdyBv70LAGmJi2SEgvfYyDxklBbENKL9diT3OvJ-OqEXY2G5XEevYvXabSPNjg29V9OCwqAuRJBYz-oBXRFx4SEMn6HcLhuqGkVIgQ', 'showInlineAds': false}], 'footerBylines': [{'regionName': 'footer1', 'items': [{'name': 'timestamp', 'label': 'On'}, {'name': 'comments', 'label': 'Comment'}, {'name': 'share', 'label': ''}]}, {'regionName': 'footer2', 'items': [{'name': 'labels', 'label': 'in'}]}, {'regionName': 'footer3', 'items': [{'name': 'location', 'label': 'Location:'}]}], 'allBylineItems': [{'name': 'timestamp', 'label': 'On'}, {'name': 'comments', 'label': 'Comment'}, {'name': 'share', 'label': ''}, {'name': 'labels', 'label': 'in'}, {'name': 'location', 'label': 'Location:'}]}, {'title': 'Categorized Posts', 'type': 'LinkList', 'sectionId': 'sec_Main_Widgets', 'id': 'LinkList08'}, {'title': 'Table of contents', 'type': 'HTML', 'sectionId': 'sec_Main_Widgets', 'id': 'HTML11'}, {'title': 'Popular Posts', 'type': 'PopularPosts', 'sectionId': 'sec_Side_Widgets', 'id': 'PopularPosts01', 'posts': [{'title': 'Treasury\u2019s Strategic Weapon', 'id': 3295708644567807628}, {'title': 'Ethereum Surges: BlackRock Leads $500M ETF Inflows as Price Eyes $5,000 Target', 'id': 7435335797307441126}, {'title': 'Fnality Secures $135M to Advance Blockchain Settlement Network', 'id': 4179129564868244497}, {'title': 'Accenture (ACN): Navigating Headwinds with Strategic Resilience and Anticipated Q4 2025 Growth', 'id': 2464680180130971641}, {'title': 'US-UK Crypto Pact: Market Impact \x26 Top Tokens to Watch', 'id': 7077065855142698246}]}, {'title': 'Labels', 'type': 'Label', 'sectionId': 'sec_Side_Widgets', 'id': 'Label01'}, {'title': 'Take me back', 'type': 'HTML', 'sectionId': 'sec_Error_404', 'id': 'HTML404'}, {'title': 'Social Media Links', 'type': 'LinkList', 'sectionId': 'sec_Footer_Organization', 'id': 'LinkList21'}, {'title': 'Credit', 'type': 'HTML', 'sectionId': 'sec_Footer_Bottom', 'id': 'HTML21'}, {'title': 'Mobile Menu', 'type': 'TextList', 'sectionId': 'sec_Mobile_Menu', 'id': 'TextList99'}, {'title': 'Labels', 'type': 'Label', 'sectionId': 'sec_Theme_Hidden', 'id': 'Label41'}, {'title': '\u09af\u09cb\u0997\u09be\u09af\u09cb\u0997 \u09ab\u09b0\u09cd\u09ae', 'type': 'ContactForm', 'sectionId': 'sec_Theme_Hidden', 'id': 'ContactForm41'}, {'title': 'Pageviews last month', 'type': 'Stats', 'sectionId': 'sec_Theme_Hidden', 'id': 'Stats41'}, {'title': 'Firebase Configurations', 'type': 'LinkList', 'sectionId': 'sec_Addon_Widgets', 'id': 'LinkList61'}, {'title': 'Cookie Consent [NoTitle]', 'type': 'LinkList', 'sectionId': 'sec_Addon_Widgets', 'id': 'LinkList63'}, {'title': 'Image Uploader', 'type': 'Image', 'sectionId': 'sec_Addon_Widgets', 'id': 'Image61'}]}]);
_WidgetManager._RegisterWidget('_HeaderView', new _WidgetInfo('Header01', 'sec_Header_Title', document.getElementById('Header01'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_BlogSearchView', new _WidgetInfo('BlogSearch01', 'sec_Header_Search', document.getElementById('BlogSearch01'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_TextListView', new _WidgetInfo('TextList01', 'sec_Header_Icon', document.getElementById('TextList01'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LinkListView', new _WidgetInfo('LinkList02', 'sec_Header_Icon', document.getElementById('LinkList02'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LinkListView', new _WidgetInfo('LinkList03', 'sec_Header_Icon', document.getElementById('LinkList03'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_PageListView', new _WidgetInfo('PageList01', 'sec_Nav_Widgets_1', document.getElementById('PageList01'), {'title': 'Navigation Menu (Simple)', 'links': [{'isCurrentPage': false, 'href': 'https://www.finqura.com/', 'id': '0', 'title': 'Home'}, {'isCurrentPage': false, 'href': '#', 'title': 'Contact'}], 'mobile': false, 'showPlaceholder': true, 'hasCurrentPage': false}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_PageListView', new _WidgetInfo('PageList02', 'sec_Nav_Widgets_2', document.getElementById('PageList02'), {'title': 'Additional Links', 'links': [{'isCurrentPage': false, 'href': 'https://www.finqura.com/sitemap.xml', 'title': 'Sitemap'}, {'isCurrentPage': false, 'href': '#', 'title': 'Disclaimer'}, {'isCurrentPage': false, 'href': '#', 'title': 'Privacy'}], 'mobile': false, 'showPlaceholder': true, 'hasCurrentPage': false}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LinkListView', new _WidgetInfo('LinkList04', 'sec_Nav_Widgets_2', document.getElementById('LinkList04'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_FeaturedPostView', new _WidgetInfo('FeaturedPost01', 'sec_Top_Widgets', document.getElementById('FeaturedPost01'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_BlogView', new _WidgetInfo('Blog01', 'sec_Main_Widgets', document.getElementById('Blog01'), {'cmtInteractionsEnabled': false, 'lightboxEnabled': true, 'lightboxModuleUrl': 'https://www.blogger.com/static/v1/jsbin/4187009774-lbx.js', 'lightboxCssUrl': 'https://www.blogger.com/static/v1/v-css/828616780-lightbox_bundle.css'}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LinkListView', new _WidgetInfo('LinkList08', 'sec_Main_Widgets', document.getElementById('LinkList08'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_HTMLView', new _WidgetInfo('HTML11', 'sec_Main_Widgets', document.getElementById('HTML11'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_PopularPostsView', new _WidgetInfo('PopularPosts01', 'sec_Side_Widgets', document.getElementById('PopularPosts01'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LabelView', new _WidgetInfo('Label01', 'sec_Side_Widgets', document.getElementById('Label01'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_HTMLView', new _WidgetInfo('HTML404', 'sec_Error_404', document.getElementById('HTML404'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LinkListView', new _WidgetInfo('LinkList21', 'sec_Footer_Organization', document.getElementById('LinkList21'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_HTMLView', new _WidgetInfo('HTML21', 'sec_Footer_Bottom', document.getElementById('HTML21'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_TextListView', new _WidgetInfo('TextList99', 'sec_Mobile_Menu', document.getElementById('TextList99'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LabelView', new _WidgetInfo('Label41', 'sec_Theme_Hidden', document.getElementById('Label41'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_ContactFormView', new _WidgetInfo('ContactForm41', 'sec_Theme_Hidden', document.getElementById('ContactForm41'), {'contactFormMessageSendingMsg': 'Sending...', 'contactFormMessageSentMsg': 'Your message has been sent.', 'contactFormMessageNotSentMsg': 'Message could not be sent. Please try again later.', 'contactFormInvalidEmailMsg': 'A valid email address is required.', 'contactFormEmptyMessageMsg': 'Message field cannot be empty.', 'title': '\u09af\u09cb\u0997\u09be\u09af\u09cb\u0997 \u09ab\u09b0\u09cd\u09ae', 'blogId': '7670458792165888524', 'contactFormNameMsg': 'Name', 'contactFormEmailMsg': 'Email', 'contactFormMessageMsg': 'Message', 'contactFormSendMsg': 'Send', 'contactFormToken': 'AOuZoY6IbMvnX82rMiV18Qi21EtT5vhFIg:1759181270926', 'submitUrl': 'https://www.blogger.com/contact-form.do'}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_StatsView', new _WidgetInfo('Stats41', 'sec_Theme_Hidden', document.getElementById('Stats41'), {'title': 'Pageviews last month', 'showGraphicalCounter': false, 'showAnimatedCounter': false, 'showSparkline': true, 'statsUrl': '//www.finqura.com/b/stats?amp\x3d1\x26style\x3dBLACK_TRANSPARENT\x26timeRange\x3dLAST_WEEK\x26token\x3dAPq4FmBRFEclBfhByhdO1vOErzD1mGYTOi6mBkzeknrJJGn9-fuNzbYK-E7Rj46Fde0gIGF3NskXwse7cEb_KXw6epjWuKgmzg'}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LinkListView', new _WidgetInfo('LinkList61', 'sec_Addon_Widgets', document.getElementById('LinkList61'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_LinkListView', new _WidgetInfo('LinkList63', 'sec_Addon_Widgets', document.getElementById('LinkList63'), {}, 'displayModeFull'));
_WidgetManager._RegisterWidget('_ImageView', new _WidgetInfo('Image61', 'sec_Addon_Widgets', document.getElementById('Image61'), {'resize': false}, 'displayModeFull'));
</script>
</body>